Last reviewed · How we verify
Ovarian deficiency symptoms — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Estrace | ESTRADIOL | Pfizer | Estrogen | Estrogen receptor | 1975-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
- — Estring · FDA · approved · US
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Ovarian deficiency symptoms
- Pfizer Inc. · 1 drug in Ovarian deficiency symptoms
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Ovarian deficiency symptoms:
- Ovarian deficiency symptoms treatment updates — RSS
- Ovarian deficiency symptoms treatment updates — Atom
- Ovarian deficiency symptoms treatment updates — JSON
Cite this brief
Drug Landscape (2026). Ovarian deficiency symptoms — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ovarian-deficiency-symptoms. Accessed 2026-06-11.
Related
- Ovarian deficiency symptoms full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing